Huberman Lab
Dr. Matthew Hill: How Cannabis Impacts Health & the Potential Risks
Dr. Matthew Hill
I mean, Johnson & Johnson developed one as well, and they looked at it in social anxiety disorder. They had some moderate efficacy in their trial. So I'd say the jury's still out on exactly what we're going to do with these, but they have some potential, I think, in certain clinical settings. We just have to figure that out exactly. But I think going back to where we started this from...
0
💬
0
Comments
Log in to comment.
There are no comments yet.